Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Other Non-Current Liabilities (2016 - 2025)

Ironwood Pharmaceuticals (IRWD) has disclosed Other Non-Current Liabilities for 14 consecutive years, with $21.6 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities rose 26.56% to $21.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.6 million through Dec 2025, up 26.56% year-over-year, with the annual reading at $21.6 million for FY2025, 26.56% up from the prior year.
  • Other Non-Current Liabilities hit $21.6 million in Q4 2025 for Ironwood Pharmaceuticals, down from $22.2 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $39.8 million in Q3 2024 to a low of $1.5 million in Q2 2021.
  • Historically, Other Non-Current Liabilities has averaged $17.3 million across 5 years, with a median of $17.2 million in 2024.
  • Biggest five-year swings in Other Non-Current Liabilities: soared 478.86% in 2022 and later tumbled 44.14% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $3.5 million in 2021, then surged by 178.95% to $9.8 million in 2022, then soared by 190.96% to $28.4 million in 2023, then plummeted by 39.8% to $17.1 million in 2024, then grew by 26.56% to $21.6 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for IRWD at $21.6 million in Q4 2025, $22.2 million in Q3 2025, and $22.5 million in Q2 2025.